News Release
Second quarter 2021 net income from continuing operations was
Second Quarter Financial Results Highlight
-
Earnings before interest, taxes, depreciation and amortization ("EBITDA") from ongoing operations for Aluminum Extrusions of
$19.7 million was$6.4 million higher than the second quarter of 2020 -
EBITDA from ongoing operations for
PE Films of$9.0 million was$6.5 million lower than the second quarter of 2020 -
EBITDA from ongoing operations for
Flexible Packaging Films of$8.3 million was$1.8 million higher than the second quarter of 2020
THE IMPACT OF COVID-19 AND RELATED FINANCIAL CONSIDERATIONS
Essential Business and Employee Considerations
The Company’s priorities during the coronavirus ("COVID-19") pandemic continue to be to protect the health and safety of employees while keeping its manufacturing sites open due to the essential nature of many of its products. The Company has continued to manufacture the full range of products at its facilities.
The Company’s protocols to protect the health and well-being of its employees from COVID-19 continue to evolve with COVID-19 informed work practices and as the Company responds to recommended and mandated actions of government and health authorities. In addition, to facilitate a return to fully functional operations, the Company has undertaken an education campaign to provide employees with the most accurate and up-to-date information available, particularly from the
All three of the Company's business units are managing through supply chain disruptions, including raw material cost increases, shortages in aluminum and plastic resin and transportation delays. To offset growing cost pressures,
Financial Considerations
Approximately 62% of Bonnell Aluminum’s sales volume in 2020 was related to building and construction (“B&C”) markets (non-residential B&C of 55% and residential B&C of 7%). Non-residential B&C volume started to decline in the fourth quarter of 2020 after the fulfillment of contracts that existed at the start of the COVID-19 pandemic.
Demand has been strong during the COVID-19 pandemic for the Company’s flexible food packaging films produced by Terphane; however, temporary resin supply issues and customer inventory corrections adversely impacted second quarter sales volume versus the same period in the prior year. The Surface Protection component of
OPERATIONS REVIEW
Aluminum Extrusions
Aluminum Extrusions, which is also referred to as
|
Three Months Ended |
|
Favorable/
|
|
Six Months Ended |
|
Favorable/
|
||||||||||||||
(In thousands, except percentages) |
|
|
|
|
|||||||||||||||||
2021 |
|
2020 |
|
2021 |
|
2020 |
|
||||||||||||||
Sales volume (lbs) |
49,021 |
|
|
43,807 |
|
|
11.9 |
% |
|
93,387 |
|
|
91,124 |
|
|
2.5 |
% |
||||
Net sales |
$ |
139,281 |
|
|
$ |
106,058 |
|
|
31.3 |
% |
|
$ |
257,405 |
|
|
$ |
223,945 |
|
|
14.9 |
% |
Ongoing operations: |
|
|
|
|
|
|
|
|
|
|
|
||||||||||
EBITDA |
$ |
19,723 |
|
|
$ |
13,279 |
|
|
48.5 |
% |
|
$ |
33,024 |
|
|
$ |
24,956 |
|
|
32.3 |
% |
Depreciation & amortization |
$ |
(4,032 |
) |
|
$ |
(4,267 |
) |
|
5.5 |
% |
|
$ |
(8,162 |
) |
|
$ |
(8,380 |
) |
|
2.6 |
% |
EBIT* |
$ |
15,691 |
|
|
$ |
9,012 |
|
|
74.1 |
% |
|
$ |
24,862 |
|
|
$ |
16,576 |
|
|
50.0 |
% |
Capital expenditures |
$ |
4,326 |
|
|
$ |
1,355 |
|
|
|
|
$ |
6,773 |
|
|
$ |
2,929 |
|
|
|
||
* See the net sales and EBITDA from ongoing operations by segment statements in the Financial Statements of this press release for a reconciliation of this non-GAAP measure to the most directly comparable measure calculated in accordance with GAAP. |
Second Quarter 2021 Results vs. Second Quarter 2020 Results
Net sales (sales less freight) in the second quarter of 2021 increased versus the second quarter of 2020, primarily due to higher volume, the pass-through of higher metal costs and an increase in average selling prices to cover higher operating costs. Sales volume in the second quarter of 2021 increased by 11.9% versus the second quarter of 2020. Sales volume associated with the non-residential B&C market, which represented 55% of volume in 2020, declined 10.2% in the second quarter of 2021 versus the second quarter of 2020. Sales volume associated with specialty markets, which represented 31% of total volume in 2020, increased 44.2% in the second quarter of 2021 versus the second quarter of 2020, and sales volume associated with the automotive market, which represented 9% of total volume in 2020, increased 65.3% in the second quarter of 2021 versus the second quarter of 2020. See “The Impact of COVID-19 and Related Financial Considerations” section for more information on business conditions.
EBITDA from ongoing operations in the second quarter of 2021 increased by
First Six Months of 2021 Results vs. First Six Months 2020 Results
Net sales in the first six months of 2021 increased versus the first six months of 2020, primarily due to higher sales volume in the specialty and automotive markets, the pass-through of higher metal costs and an increase in average selling prices to cover higher operating costs. Sales volume in the first six months of 2021 increased by 2.5% versus the first six months of 2020.
EBITDA from ongoing operations in the first six months of 2021 increased by
Projected Capital Expenditures and Depreciation & Amortization
Capital expenditures for
|
Three Months Ended |
|
Favorable/
|
|
Six Months Ended |
|
Favorable/
|
||||||||||||||
(In thousands, except percentages) |
|
|
|
|
|||||||||||||||||
2021 |
|
2020 |
|
2021 |
|
2020 |
|
||||||||||||||
Sales volume (lbs) |
10,538 |
|
|
11,613 |
|
|
(9.3 |
)% |
|
20,782 |
|
|
23,792 |
|
|
(12.7 |
)% |
||||
Net sales |
$ |
31,430 |
|
|
$ |
40,203 |
|
|
(21.8 |
)% |
|
$ |
59,384 |
|
|
$ |
77,004 |
|
|
(22.9 |
)% |
Ongoing operations: |
|
|
|
|
|
|
|
|
|
|
|
||||||||||
EBITDA |
$ |
9,001 |
|
|
$ |
15,471 |
|
|
(41.8 |
)% |
|
$ |
16,213 |
|
|
$ |
27,884 |
|
|
(41.9 |
)% |
Depreciation & amortization |
$ |
(1,671 |
) |
|
$ |
(1,589 |
) |
|
(5.2 |
)% |
|
$ |
(3,090 |
) |
|
$ |
(3,083 |
) |
|
(0.2 |
)% |
EBIT* |
$ |
7,330 |
|
|
$ |
13,882 |
|
|
(47.2 |
)% |
|
$ |
13,123 |
|
|
$ |
24,801 |
|
|
(47.1 |
)% |
Capital expenditures |
$ |
500 |
|
|
$ |
1,423 |
|
|
|
|
$ |
1,733 |
|
|
$ |
3,044 |
|
|
|
||
* See the net sales and EBITDA from ongoing operations by segment statements in the Financial Statements of this press release for a reconciliation of this non-GAAP measure to the most directly comparable measure calculated in accordance with GAAP. |
Second Quarter 2021 Results vs. Second Quarter 2020 Results
Net sales declined by
EBITDA from ongoing operations in the second quarter of 2021 decreased by
-
A
$5.7 million decrease from Surface Protection related to lower sales associated with the customer product transitions ($7.2 million ) and higher resin costs, net of existing index based pricing ($1.0 million ), partially offset by higher sales of products unrelated to the customer product transitions ($0.9 million ), higher productivity ($0.7 million ), lower research and development expenses ($0.4 million ) and lower other operating costs ($0.5 million ); and -
A
$0.6 million decrease fromPottsville Packaging primarily related to higher resin costs.
Refer to Item 3. Quantitative and Qualitative Disclosures About Market Risk of the Company's Form 10-Q for the period ended
Customer Product Transitions in Surface Protection
The Surface Protection component of
The Company previously reported the risk that a portion of its film products used in surface protection applications will be made obsolete by possible future customer product transitions to less costly alternative processes or materials. These transitions principally relate to one customer. The Company believes that previously reported delays in this customer's transitions have been resolved by the customer and much of the remaining transitions are expected to occur by the end of 2021. Under this scenario, the Company estimates that the contribution to EBITDA from ongoing operations for
First Six Months of 2021 Results vs. First Six Months 2020 Results
Net sales in the first six months of 2021 decreased versus the first six months 2020, primarily due to lower volume and unfavorable mix associated with the previously disclosed customer product transitions in Surface Protection.
EBITDA from ongoing operation in the first six months of 2021 decreased by
-
A
$11.1 million decrease from Surface Protection primarily related to lower sales and unfavorable mix associated with the customer product transitions ($13.0 million ) and higher resin costs, net of existing index based pricing ($1.7 million ), partially offset by higher sales of products unrelated to the customer product transitions ($1.8 million ) and higher productivity ($2.0 million ); and -
A
$1.0 million decrease fromPottsville Packaging primarily related to higher resin costs.
Projected Capital Expenditures and Depreciation & Amortization
Capital expenditures for
|
Three Months Ended |
|
Favorable/
|
|
Six Months Ended |
|
Favorable/
|
||||||||||||||
(In thousands, except percentages) |
|
|
|
|
|||||||||||||||||
2021 |
|
2020 |
|
2021 |
|
2020 |
|
||||||||||||||
Sales volume (lbs) |
24,230 |
|
|
29,195 |
|
|
(17.0 |
)% |
|
51,638 |
|
|
54,974 |
|
|
(6.1 |
)% |
||||
Net sales |
$ |
33,374 |
|
|
$ |
34,104 |
|
|
(2.1 |
)% |
|
$ |
65,895 |
|
|
$ |
64,678 |
|
|
1.9 |
% |
Ongoing operations: |
|
|
|
|
|
|
|
|
|
|
|
||||||||||
EBITDA |
$ |
8,277 |
|
|
$ |
6,495 |
|
|
27.4 |
% |
|
$ |
17,901 |
|
|
$ |
13,048 |
|
|
37.2 |
% |
Depreciation & amortization |
$ |
(506 |
) |
|
$ |
(436 |
) |
|
(16.1 |
)% |
|
$ |
(972 |
) |
|
$ |
(864 |
) |
|
(12.5 |
)% |
EBIT* |
$ |
7,771 |
|
|
$ |
6,059 |
|
|
28.3 |
% |
|
$ |
16,929 |
|
|
$ |
12,184 |
|
|
38.9 |
% |
Capital expenditures |
$ |
1,117 |
|
|
$ |
417 |
|
|
|
|
$ |
2,388 |
|
|
$ |
1,265 |
|
|
|
||
* See the net sales and EBITDA from ongoing operations by segment statements in the Financial Statements of this press release for a reconciliation of this non-GAAP measure to the most directly comparable measure calculated in accordance with GAAP. |
Second Quarter 2021 Results vs. Second Quarter 2020 Results
Sales volume declined by 17.0% during the second quarter of 2021 versus the second quarter of 2020, primarily due to temporary resin supply issues impacting production and lower demand, which the Company believes was related to customer inventory corrections in
EBITDA from ongoing operations in the second quarter of 2021 increased by
-
Lower sales volume (
$2.8 million ), partially offset by favorable product mix ($0.7 million ), lower fixed ($0.5 million ) and variable ($0.2 million ) costs, higher selling prices from the pass-through of higher resin costs ($0.5 million ) and lower selling and general administration expenses ($0.6 million ); -
Net favorable foreign currency translation of Real-denominated operating costs (
$2.2 million ); and -
Higher foreign currency transaction losses of
$0.1 million in the second quarter of 2021 versus the second quarter of 2020.
First Six Months of 2021 Results vs. First Six Months 2020 Results
Sales volume declined by 6.1% during the first six months of 2021 versus the first six months of 2020, primarily due to the factors adversely impacting the second quarter of 2021 mentioned above. Net sales in the first six months of 2021 increased 1.9% compared to the first six months of 2020, primarily due to favorable product mix and higher selling prices from the pass-through of higher resin costs, partially offset by lower sales volume.
EBITDA from ongoing operations in the first six months of 2021 increased by
-
Higher selling prices from the pass-through of higher resin costs (
$1.6 million ), favorable product mix ($1.4 million ), lower variable costs ($0.4 million ) and lower selling and general administration expenses ($0.5 million ), partially offset by lower sales volume ($1.7 million ) and higher fixed costs ($0.6 million ); -
Net favorable currency translation of Real-denominated operating costs (
$3.5 million ); -
Foreign currency transaction loss of
$0.1 million in the first six months of 2021 versus losses of$0.2 million in the first six months of 2020; and -
Lower value-added tax credits received in the first six months of 2021 (
$0.5 million ) compared with the first six months of 2020 ($1.2 million ).
Projected Capital Expenditures and Depreciation & Amortization
Capital expenditures for
Corporate Expenses, Interest, Taxes & Other
Corporate expenses, net, increased in the first six months of 2021 versus the first six months of 2020, primarily due to higher employee-related compensation (
Interest expense was
The effective tax rate used to compute income tax expense (benefit) for continuing operations in the first six months of 2021 was 22.5%, compared to 27.1% in the first six months of 2020. The effective tax rate from ongoing operations comparable to the earnings reconciliation table provided in Note (a) of the Notes to Financial Tables in this press release was 22.3% for the first six months of 2021 versus 21.4% for the first six months of 2020 (see also Note (f) of the Notes to Financial Tables). Refer to Note 12 of the Company's Form 10-Q for the period ended
Pension expense was
Tredegar owns approximately 19% of kaleo, Inc. (“kaléo”), which makes and sells an epinephrine delivery device under the name AUVI-Q®. The Company accounts for its investment in kaléo using a fair value method. The Company’s estimate of the fair value of its interest in kaléo at
Total debt was
FORWARD-LOOKING AND CAUTIONARY STATEMENTS
Some of the information contained in this press release may constitute “forward-looking statements” within the meaning of the “safe harbor” provisions of the Private Securities Litigation Reform Act of 1995. When the Company uses the words “believe,” “estimate,” “anticipate,” “appear to,” “expect,” “project,” “plan,” “likely,” “may” and similar expressions, it does so to identify forward-looking statements. Such statements are based on the Company's then current expectations and are subject to a number of risks and uncertainties that could cause actual results to differ materially from those addressed in the forward-looking statements. It is possible that the Company's actual results and financial condition may differ, possibly materially, from the anticipated results and financial condition indicated in or implied by these forward-looking statements. In addition, the Company's current projections for its businesses could be materially affected by the highly uncertain impact of the COVID-19 pandemic. As a consequence, the Company's results could differ significantly from its projections, depending on, among other things, the ultimate impact of the pandemic on employees, supply chains, customers and the
- loss or gain of sales to significant customers on which the Company's business is highly dependent;
- inability to achieve sales to new customers to replace lost business;
- inability to develop, efficiently manufacture and deliver new products at competitive prices;
- failure of the Company's customers to achieve success or maintain market share;
- failure to protect our intellectual property rights;
-
risks of doing business in countries outside the
U.S. that affect our international operations; - political, economic, and regulatory factors concerning the Company's products;
- uncertain economic conditions in countries in which the Company does business;
- competition from other manufacturers, including manufacturers in lower-cost countries and manufacturers benefiting from government subsidies;
- impact of fluctuations in foreign exchange rates;
- a change in the amount of the Company's underfunded defined benefit pension plan liability;
- an increase in the operating costs incurred by the Company's business units, including, for example, the cost of raw materials and energy;
- inability to successfully identify, complete or integrate strategic acquisitions; failure to realize the expected benefits of such acquisitions and assumption of unanticipated risks in such acquisitions;
- disruption to the Company's manufacturing facilities;
- the impact of public health epidemics on employees, production and the global economy, such as the COVID-19 pandemic;
- an information technology system failure or breach;
- volatility and uncertainty of the valuation of the Company's investment in kaléo;
-
the impact of the imposition of tariffs and sanctions on imported aluminum ingot used by
Bonnell Aluminum ; -
the impact of new tariffs, duties or other trade restrictions imposed as a result of rising trade tensions between the
U.S. and other countries; -
the termination of anti-dumping duties on products imported to
Brazil that compete with products produced byFlexible Packaging ; - failure to establish and maintain effective internal control over financial reporting;
and the other factors discussed in the reports Tredegar files with or furnishes to the
Tredegar does not undertake, and expressly disclaims any duty, to update any forward-looking statement made in this press release to reflect any change in management’s expectations or any change in conditions, assumptions or circumstances on which such statements are based, except as required by applicable law.
To the extent that the financial information portion of this press release contains non-GAAP financial measures, it also presents both the most directly comparable financial measures calculated and presented in accordance with GAAP and a quantitative reconciliation of the difference between any such non-GAAP measures and such comparable GAAP financial measures. Reconciliations of non-GAAP financial measures are provided in the Notes to the Financial Tables included with this press release and can also be found within “Presentations” in the “Investors” section of our website, www.tredegar.com.
Tredegar uses its website as a channel of distribution of material Company information. Financial information and other material information regarding Tredegar is posted on and assembled in the “Investors” section of its website.
|
||||||||||||||||
Condensed Consolidated Statements of Income (Loss) |
||||||||||||||||
(In Thousands, Except Per-Share Data) |
||||||||||||||||
(Unaudited) |
||||||||||||||||
|
|
|
|
|
||||||||||||
|
|
Three Months Ended |
|
Six Months Ended |
||||||||||||
|
|
|
|
|
||||||||||||
|
|
2021 |
|
2020 |
|
2021 |
|
2020 |
||||||||
Sales |
|
$ |
211,129 |
|
|
$ |
186,259 |
|
|
$ |
395,951 |
|
|
$ |
378,396 |
|
Other income (expense), net (c)(d)(h) |
|
8,122 |
|
|
168 |
|
|
8,882 |
|
|
(25,964 |
) |
||||
|
|
219,251 |
|
|
186,427 |
|
|
404,833 |
|
|
352,432 |
|
||||
|
|
|
|
|
|
|
|
|
||||||||
Cost of goods sold (c) |
|
158,692 |
|
|
134,035 |
|
|
299,977 |
|
|
279,204 |
|
||||
Freight |
|
7,044 |
|
|
5,894 |
|
|
13,267 |
|
|
12,769 |
|
||||
Selling, R&D and general expenses (c) |
|
21,711 |
|
|
23,427 |
|
|
41,816 |
|
|
45,641 |
|
||||
Amortization of intangibles |
|
723 |
|
|
753 |
|
|
1,446 |
|
|
1,511 |
|
||||
Pension and postretirement benefits |
|
3,540 |
|
|
3,567 |
|
|
7,080 |
|
|
7,134 |
|
||||
Interest expense |
|
891 |
|
|
549 |
|
|
1,713 |
|
|
1,104 |
|
||||
Asset impairments and costs associated with exit and disposal activities, net of adjustments (c) |
|
199 |
|
|
10 |
|
|
368 |
|
|
71 |
|
||||
|
|
— |
|
|
— |
|
|
— |
|
|
13,696 |
|
||||
|
|
192,800 |
|
|
168,235 |
|
|
365,667 |
|
|
361,130 |
|
||||
Income (loss) from continuing operations before income taxes |
|
26,451 |
|
|
18,192 |
|
|
39,166 |
|
|
(8,698 |
) |
||||
Income tax expense (benefit) (c) |
|
5,723 |
|
|
3,860 |
|
|
8,820 |
|
|
(2,366 |
) |
||||
Net income (loss) from continuing operations |
|
20,728 |
|
|
14,332 |
|
|
30,346 |
|
|
(6,332 |
) |
||||
Income (loss) from discontinued operations, net of tax |
|
508 |
|
|
(3,136 |
) |
|
(79 |
) |
|
(4,794 |
) |
||||
Net income (loss) |
|
$ |
21,236 |
|
|
$ |
11,196 |
|
|
$ |
30,267 |
|
|
$ |
(11,126 |
) |
|
|
|
|
|
|
|
|
|
||||||||
Earnings (loss) per share: |
|
|
|
|
|
|
|
|
||||||||
Basic: |
|
|
|
|
|
|
|
|
||||||||
Continuing operations |
|
$ |
0.62 |
|
|
$ |
0.43 |
|
|
$ |
0.91 |
|
|
$ |
(0.19 |
) |
Discontinued operations |
|
0.02 |
|
|
(0.10 |
) |
|
— |
|
|
(0.14 |
) |
||||
Basic earnings (loss) per share |
|
$ |
0.64 |
|
|
$ |
0.33 |
|
|
$ |
0.91 |
|
|
$ |
(0.33 |
) |
Diluted: |
|
|
|
|
|
|
|
|
||||||||
Continuing operations |
|
$ |
0.61 |
|
|
$ |
0.43 |
|
|
$ |
0.90 |
|
|
$ |
(0.19 |
) |
Discontinued operations |
|
0.02 |
|
|
(0.10 |
) |
|
— |
|
|
(0.14 |
) |
||||
Diluted earnings (loss) per share |
|
$ |
0.63 |
|
|
$ |
0.33 |
|
|
$ |
0.90 |
|
|
$ |
(0.33 |
) |
|
|
|
|
|
|
|
|
|
||||||||
Shares used to compute earnings (loss) per share: |
|
|
|
|
|
|
|
|
||||||||
Basic |
|
33,594 |
|
|
33,435 |
|
|
33,500 |
|
|
33,374 |
|
||||
Diluted |
|
33,740 |
|
|
33,436 |
|
|
33,692 |
|
|
33,374 |
|
|
|||||||||||||||
|
|||||||||||||||
(In Thousands) |
|||||||||||||||
(Unaudited) |
|||||||||||||||
|
|
|
|
||||||||||||
|
Three Months Ended |
|
Six Months Ended |
||||||||||||
|
|
|
|
||||||||||||
|
2021 |
|
2020 |
|
2021 |
|
2020 |
||||||||
|
|
|
|
|
|
|
|
||||||||
Aluminum Extrusions |
$ |
139,281 |
|
|
$ |
106,058 |
|
|
$ |
257,405 |
|
|
$ |
223,945 |
|
|
31,430 |
|
|
40,203 |
|
|
59,384 |
|
|
77,004 |
|
||||
|
33,374 |
|
|
34,104 |
|
|
65,895 |
|
|
64,678 |
|
||||
Total net sales |
204,085 |
|
|
180,365 |
|
|
382,684 |
|
|
365,627 |
|
||||
Add back freight |
7,044 |
|
|
5,894 |
|
|
13,267 |
|
|
12,769 |
|
||||
Sales as shown in the Condensed Consolidated Statements of Income |
$ |
211,129 |
|
|
$ |
186,259 |
|
|
$ |
395,951 |
|
|
$ |
378,396 |
|
EBITDA from Ongoing Operations |
|
|
|
|
|
|
|
||||||||
Aluminum Extrusions: |
|
|
|
|
|
|
|
||||||||
Ongoing operations: |
|
|
|
|
|
|
|
||||||||
EBITDA (b) |
$ |
19,723 |
|
|
$ |
13,279 |
|
|
$ |
33,024 |
|
|
$ |
24,956 |
|
Depreciation & amortization |
(4,032 |
) |
|
(4,267 |
) |
|
(8,162 |
) |
|
(8,380 |
) |
||||
EBIT (b) |
15,691 |
|
|
9,012 |
|
|
24,862 |
|
|
16,576 |
|
||||
Plant shutdowns, asset impairments, restructurings and other (c) |
(246 |
) |
|
(1,230 |
) |
|
(63 |
) |
|
(1,918 |
) |
||||
|
— |
|
|
— |
|
|
— |
|
|
(13,696 |
) |
||||
|
|
|
|
|
|
|
|
||||||||
Ongoing operations: |
|
|
|
|
|
|
|
||||||||
EBITDA (b) |
9,001 |
|
|
15,471 |
|
|
16,213 |
|
|
27,884 |
|
||||
Depreciation & amortization |
(1,671 |
) |
|
(1,589 |
) |
|
(3,090 |
) |
|
(3,083 |
) |
||||
EBIT (b) |
7,330 |
|
|
13,882 |
|
|
13,123 |
|
|
24,801 |
|
||||
Plant shutdowns, asset impairments, restructurings and other (c) |
(151 |
) |
|
(139 |
) |
|
(275 |
) |
|
(167 |
) |
||||
|
|
|
|
|
|
|
|
||||||||
Ongoing operations: |
|
|
|
|
|
|
|
||||||||
EBITDA (b) |
8,277 |
|
|
6,495 |
|
|
17,901 |
|
|
13,048 |
|
||||
Depreciation & amortization |
(506 |
) |
|
(436 |
) |
|
(972 |
) |
|
(864 |
) |
||||
EBIT (b) |
7,771 |
|
|
6,059 |
|
|
16,929 |
|
|
12,184 |
|
||||
Plant shutdowns, asset impairments, restructurings and other (c) |
8,452 |
|
|
(10 |
) |
|
8,414 |
|
|
(10 |
) |
||||
Total |
38,847 |
|
|
27,574 |
|
|
62,990 |
|
|
37,770 |
|
||||
Interest income |
25 |
|
|
5 |
|
|
32 |
|
|
32 |
|
||||
Interest expense |
891 |
|
|
549 |
|
|
1,713 |
|
|
1,104 |
|
||||
Gain (loss) on investment in kaléo accounted for under fair value method (d) |
200 |
|
|
1,300 |
|
|
918 |
|
|
(24,800 |
) |
||||
Stock option-based compensation costs |
675 |
|
|
683 |
|
|
1,144 |
|
|
1,258 |
|
||||
Corporate expenses, net (c) |
11,055 |
|
|
9,455 |
|
|
21,917 |
|
|
19,338 |
|
||||
Income (loss) from continuing operations before income taxes |
26,451 |
|
|
18,192 |
|
|
39,166 |
|
|
(8,698 |
) |
||||
Income tax expense (benefit) |
5,723 |
|
|
3,860 |
|
|
8,820 |
|
|
(2,366 |
) |
||||
Net income (loss) from continuing operations |
20,728 |
|
|
14,332 |
|
|
30,346 |
|
|
(6,332 |
) |
||||
Net income (loss) from discontinued operations, net of tax |
508 |
|
|
(3,136 |
) |
|
(79 |
) |
|
(4,794 |
) |
||||
Net income (loss) |
$ |
21,236 |
|
|
$ |
11,196 |
|
|
$ |
30,267 |
|
|
$ |
(11,126 |
) |
|
||||||||
Condensed Consolidated Balance Sheets |
||||||||
(In Thousands) |
||||||||
(Unaudited) |
||||||||
|
|
|
|
|
||||
|
|
|
|
|
||||
Assets |
|
|
|
|
||||
Cash & cash equivalents |
|
$ |
18,298 |
|
|
$ |
11,846 |
|
Accounts & other receivables, net |
|
99,652 |
|
|
86,327 |
|
||
Income taxes recoverable |
|
141 |
|
|
2,807 |
|
||
Inventories |
|
81,161 |
|
|
66,437 |
|
||
Prepaid expenses & other |
|
15,219 |
|
|
19,679 |
|
||
Current assets of discontinued operations |
|
151 |
|
|
1,339 |
|
||
Total current assets |
|
214,622 |
|
|
188,435 |
|
||
Property, plant & equipment, net |
|
168,557 |
|
|
166,545 |
|
||
Right-of-use leased assets |
|
14,973 |
|
|
16,037 |
|
||
Investment in kaléo (cost basis of |
|
35,200 |
|
|
34,600 |
|
||
Identifiable intangible assets, net |
|
17,408 |
|
|
18,820 |
|
||
|
|
67,708 |
|
|
67,708 |
|
||
Deferred income taxes |
|
14,205 |
|
|
19,068 |
|
||
Other assets |
|
2,691 |
|
|
3,506 |
|
||
Non-current assets of discontinued operations |
|
151 |
|
|
151 |
|
||
Total assets |
|
$ |
535,515 |
|
|
$ |
514,870 |
|
Liabilities and Shareholders’ Equity |
|
|
|
|
||||
Accounts payable |
|
$ |
113,202 |
|
|
$ |
89,702 |
|
Accrued expenses |
|
33,272 |
|
|
40,741 |
|
||
Lease liability, short-term |
|
2,078 |
|
|
2,082 |
|
||
Income taxes payable |
|
767 |
|
|
706 |
|
||
Current liabilities of discontinued operations |
|
1,033 |
|
|
7,521 |
|
||
Total current liabilities |
|
150,352 |
|
|
140,752 |
|
||
Lease liability, long-term |
|
13,904 |
|
|
14,949 |
|
||
Long-term debt |
|
117,000 |
|
|
134,000 |
|
||
Pension and other postretirement benefit obligations, net |
|
105,161 |
|
|
110,585 |
|
||
Other non-current liabilities |
|
5,758 |
|
|
5,529 |
|
||
Shareholders’ equity |
|
143,340 |
|
|
109,055 |
|
||
Total liabilities and shareholders’ equity |
|
$ |
535,515 |
|
|
$ |
514,870 |
|
|
||||||||
Condensed Consolidated Statements of Cash Flows |
||||||||
(In Thousands) |
||||||||
(Unaudited) |
||||||||
|
|
|
||||||
|
|
Six Months Ended |
||||||
|
|
2021 |
|
2020 |
||||
Cash flows from operating activities: |
|
|
|
|
||||
Net income (loss) |
|
$ |
30,267 |
|
|
$ |
(11,126 |
) |
Adjustments for noncash items: |
|
|
|
|
||||
Depreciation |
|
10,875 |
|
|
15,357 |
|
||
Amortization of intangibles |
|
1,446 |
|
|
1,511 |
|
||
Reduction of right-of-use lease asset |
|
1,066 |
|
|
1,402 |
|
||
|
|
— |
|
|
13,696 |
|
||
Deferred income taxes |
|
2,477 |
|
|
(8,461 |
) |
||
Accrued pension income and post-retirement benefits |
|
7,080 |
|
|
7,134 |
|
||
Stock-based compensation expense |
|
2,444 |
|
|
2,520 |
|
||
(Gain) loss on investment accounted for under the fair value method |
|
(600 |
) |
|
24,800 |
|
||
Changes in assets and liabilities: |
|
|
|
|
||||
Accounts and other receivables |
|
(12,840 |
) |
|
2,303 |
|
||
Inventories |
|
(14,020 |
) |
|
(8,515 |
) |
||
Income taxes recoverable/payable |
|
2,680 |
|
|
8,799 |
|
||
Prepaid expenses and other |
|
7,267 |
|
|
(1,912 |
) |
||
Accounts payable and accrued expenses |
|
8,040 |
|
|
(6,936 |
) |
||
Lease liability |
|
(1,051 |
) |
|
(1,496 |
) |
||
Pension and postretirement benefit plan contributions |
|
(4,020 |
) |
|
(2,130 |
) |
||
Other, net |
|
396 |
|
|
(884 |
) |
||
Net cash provided by operating activities |
|
41,507 |
|
|
36,062 |
|
||
Cash flows from investing activities: |
|
|
|
|
||||
Capital expenditures |
|
(11,324 |
) |
|
(8,806 |
) |
||
Net cash used in investing activities |
|
(11,324 |
) |
|
(8,806 |
) |
||
Cash flows from financing activities: |
|
|
|
|
||||
Borrowings |
|
34,000 |
|
|
25,000 |
|
||
Debt principal payments |
|
(51,000 |
) |
|
(33,000 |
) |
||
Dividends paid |
|
(8,070 |
) |
|
(8,025 |
) |
||
Other |
|
915 |
|
|
(586 |
) |
||
Net cash used in financing activities |
|
(24,155 |
) |
|
(16,611 |
) |
||
Effect of exchange rate changes on cash |
|
424 |
|
|
(2,137 |
) |
||
Increase in cash and cash equivalents |
|
6,452 |
|
|
8,508 |
|
||
Cash and cash equivalents at beginning of period |
|
11,846 |
|
|
31,422 |
|
||
Cash and cash equivalents at end of period |
|
$ |
18,298 |
|
|
$ |
39,930 |
|
Notes to the Financial Tables
(Unaudited)
(a) |
Tredegar’s presentation of net income (loss) and diluted earnings (loss) per share from ongoing operations are non-GAAP financial measures that exclude the effects of gains or losses associated with plant shutdowns, asset impairments and restructurings, gains or losses from the sale of assets, goodwill impairment charges, discontinued operations and other items (which includes unrealized gains and losses for an investment accounted for under the fair value method) which have been presented separately and removed from net income (loss) from continuing operations and diluted earnings (loss) per share as reported under GAAP. Net income (loss) and diluted earnings (loss) per share from ongoing operations are key financial and analytical measures used by management to gauge the operating performance of Tredegar’s ongoing operations. They are not intended to represent the stand-alone results for Tredegar’s ongoing operations under GAAP and should not be considered as an alternative to net income (loss) from continuing operations or earnings (loss) per share as defined by GAAP. They exclude items that management believes do not relate to Tredegar’s ongoing operations. A reconciliation to net income (loss) and diluted earnings (loss) per share from ongoing operations for the three and six months ended |
|
|
Three Months Ended
|
|
Six Months Ended
|
||||||||||||
($ in millions, except per share data) |
|
2021 |
|
2020 |
|
2021 |
|
2020 |
||||||||
Net income (loss) from continuing operations as reported under GAAP2 |
|
$ |
20.7 |
|
|
$ |
14.3 |
|
|
$ |
30.3 |
|
|
$ |
(6.3 |
) |
After-tax effects of: |
|
|
|
|
|
|
|
|
||||||||
(Gains) losses associated with plant shutdowns, asset impairments and restructurings |
|
0.1 |
|
|
— |
|
|
0.3 |
|
|
— |
|
||||
(Gains) losses from sale of assets and other: |
|
|
|
|
|
|
|
|
||||||||
(Gain) loss associated with the investment in kaléo |
|
(0.1 |
) |
|
(0.9 |
) |
|
(0.7 |
) |
|
19.5 |
|
||||
One-time tax credit in |
|
(6.6 |
) |
|
— |
|
|
(6.6 |
) |
|
— |
|
||||
Other |
|
2.0 |
|
|
2.6 |
|
|
2.9 |
|
|
4.2 |
|
||||
|
|
— |
|
|
— |
|
|
— |
|
|
10.5 |
|
||||
Net income (loss) from ongoing operations2 |
|
$ |
16.1 |
|
|
$ |
16.0 |
|
|
$ |
26.2 |
|
|
$ |
27.9 |
|
|
|
|
|
|
|
|
|
|
||||||||
Earnings (loss) per share from continuing operations as reported under GAAP (diluted) |
|
$ |
0.61 |
|
|
$ |
0.43 |
|
|
$ |
0.90 |
|
|
$ |
(0.19 |
) |
After-tax effects per diluted share of: |
|
|
|
|
|
|
|
|
||||||||
(Gains) losses associated with plant shutdowns, asset impairments and restructurings |
|
— |
|
|
— |
|
|
0.01 |
|
|
— |
|
||||
(Gains) losses from sale of assets and other: |
|
|
|
|
|
|
|
|
||||||||
(Gain) loss associated with the investment in kaléo |
|
— |
|
|
(0.03 |
) |
|
(0.02 |
) |
|
0.59 |
|
||||
One-time tax credit in |
|
(0.20 |
) |
|
— |
|
|
(0.20 |
) |
|
— |
|
||||
Other |
|
0.07 |
|
|
0.08 |
|
|
0.09 |
|
|
0.13 |
|
||||
|
|
— |
|
|
— |
|
|
— |
|
|
0.32 |
|
||||
Earnings (loss) per share from ongoing operations (diluted) |
|
$ |
0.48 |
|
|
$ |
0.48 |
|
|
$ |
0.78 |
|
|
$ |
0.85 |
|
1. For more information, see Note 13 in the Notes to Financial Statements in the Form 10-Q for the quarter ended |
||||||||||||||||
2. Reconciliations of the pre-tax and post-tax balances attributed to net income (loss) are shown in Note (f). |
(b) |
EBITDA (earnings before interest, taxes, depreciation and amortization) from ongoing operations is the key profitability metric used by the Company’s chief operating decision maker to assess segment financial performance. For more business segment information, see Note 11 in the Notes to Financial Statements in the Form 10-Q for the quarter ended |
|
EBIT (earnings before interest and taxes) from ongoing operations is a non-GAAP financial measure included in the accompanying tables and the reconciliation of segment financial information to consolidated results for the Company in the net sales and EBITDA from ongoing operations by segment statements. It is not intended to represent the stand-alone results for Tredegar’s ongoing operations under GAAP and should not be considered as an alternative to net income (loss) from continuing operations as defined by GAAP. EBIT is a widely understood and utilized metric that is meaningful to certain investors. The Company believes that including this financial metric in the reconciliation of management’s performance metric, EBITDA from ongoing operations, provides useful information to those investors that primarily utilize EBIT to analyze the Company’s core operations. |
||
|
||
(c) |
Gains and losses associated with plant shutdowns, asset impairments, restructurings and other items for the three and six months ended |
|
Three Months Ended
|
Six Months Ended
|
||||||||||
($ in millions) |
Pre-Tax |
Net of Tax |
Pre-Tax |
Net of Tax |
||||||||
Aluminum Extrusions: |
|
|
|
|
||||||||
(Gains) losses from sale of assets, investment writedowns and other items: |
|
|
|
|
||||||||
COVID-19-related expenses, net of relief 2 |
$ |
0.3 |
|
$ |
0.2 |
|
$ |
0.1 |
|
$ |
0.1 |
|
Total for Aluminum Extrusions |
$ |
0.3 |
|
$ |
0.2 |
|
$ |
0.1 |
|
$ |
0.1 |
|
|
|
|
|
|
||||||||
(Gains) losses from sale of assets, investment writedowns and other items: |
|
|
|
|
||||||||
COVID-19-related expenses2 |
$ |
0.1 |
|
$ |
0.1 |
|
$ |
0.3 |
|
$ |
0.2 |
|
Total for |
$ |
0.1 |
|
$ |
0.1 |
|
$ |
0.3 |
|
$ |
0.2 |
|
|
|
|
|
|
||||||||
(Gains) losses from sale of assets, investment writedowns and other items: |
|
|
|
|
||||||||
One-time tax credit in |
$ |
(8.5 |
) |
$ |
(6.6 |
) |
$ |
(8.5 |
) |
$ |
(6.6 |
) |
COVID-19-related expenses2 |
— |
|
— |
|
0.1 |
|
0.1 |
|
||||
Total for |
$ |
(8.5 |
) |
$ |
(6.6 |
) |
$ |
(8.4 |
) |
$ |
(6.5 |
) |
Corporate: |
|
|
||||||||||
(Gains) losses associated with plant shutdowns, asset impairments and restructurings: |
|
|
|
|
||||||||
Maintenance costs associated with held-for-sale assets |
0.2 |
|
0.1 |
|
$ |
0.4 |
|
$ |
0.3 |
|
||
(Gain) losses from sale of assets, investment writedowns and other items: |
|
|
|
|
||||||||
Professional fees associated with: remediation activities and other costs relating to the Company’s material weaknesses in internal control over financial reporting; and business development activities1 |
1.7 |
|
1.6 |
|
2.6 |
|
2.2 |
|
||||
Write-down of investment in |
0.4 |
|
0.3 |
|
0.5 |
|
0.4 |
|
||||
Stock compensation expense associated with the fair value remeasurement of awards granted at the time of the 2020 special dividend1 |
0.1 |
|
— |
|
0.5 |
|
0.3 |
|
||||
Transition service fees, net of corporate costs associated with the divested |
(0.3 |
) |
(0.2 |
) |
(0.6 |
) |
(0.4 |
) |
||||
Total for Corporate |
$ |
2.1 |
|
$ |
1.8 |
|
$ |
3.4 |
|
$ |
2.8 |
|
1. Included in “Selling, R&D and general expenses” in the condensed consolidated statements of income. |
||||||||||||
2. Included in “Other income (expense), net” in the condensed consolidated statements of income. |
||||||||||||
3. For more information, see Note 13 in the Notes to Financial Statements in the Form 10-Q for the quarter ended |
|
Three Months Ended
|
Six Months Ended
|
||||||||||
($ in millions) |
Pre-Tax |
Net of Tax |
Pre-Tax |
Net of Tax |
||||||||
Aluminum Extrusions: |
|
|
|
|
||||||||
(Gains) losses from sale of assets, investment writedowns and other items: |
|
|
|
|
||||||||
Consulting expenses for enterprise resource planning feasibility study2 |
$ |
0.2 |
|
$ |
0.2 |
|
0.9 |
|
0.7 |
|
||
COVID-19-related expenses, net of relief 3 |
0.9 |
|
0.8 |
|
0.9 |
|
0.8 |
|
||||
Total for Aluminum Extrusions |
$ |
1.1 |
|
$ |
1.0 |
|
$ |
1.8 |
|
$ |
1.5 |
|
|
|
|
|
|
||||||||
(Gains) losses from sale of assets, investment writedowns and other items: |
|
|
|
|
||||||||
COVID-19-related expenses3 |
$ |
0.1 |
|
$ |
0.1 |
|
$ |
0.1 |
|
$ |
0.1 |
|
Total for |
$ |
0.1 |
|
$ |
0.1 |
|
$ |
0.1 |
|
$ |
0.1 |
|
Corporate: |
|
|
|
|
||||||||
Professional fees associated with: remediation activities and other costs relating to the Company’s material weaknesses in internal control over financial reporting; and business development activities2 |
1.8 |
|
1.4 |
|
3.6 |
|
3.0 |
|
||||
Write-down of investment in |
— |
|
— |
|
0.2 |
|
0.1 |
|
||||
Accelerated recognition of stock-based compensation expense2 |
0.1 |
|
0.1 |
|
0.1 |
|
0.1 |
|
||||
|
— |
|
— |
|
— |
|
(0.6 |
) |
||||
Total for Corporate |
$ |
1.9 |
|
$ |
1.5 |
|
$ |
3.9 |
|
$ |
2.6 |
|
1. Included in "Income tax expense (benefit)" in condensed consolidated statements of income. |
||||||||||||
2. Included in “Selling, R&D and general expenses” in the condensed consolidated statements of income. |
||||||||||||
3. Included in “Other income (expense), net” in the condensed consolidated statements of income. |
(d) |
|
A gain on the Company’s investment in kaléo of |
|
||
(e) |
In the first quarter of 2020, the operations of Aluminum Extrusions’ |
|
|
||
|
||
(f) |
|
Tredegar’s presentation of net income (loss) from ongoing operations is a non-GAAP financial measure that excludes the effects of gains or losses associated with plant shutdowns, asset impairments and restructurings, gains or losses from the sale of assets, goodwill impairment charges, discontinued operations, and other items (which includes unrealized gains and losses for an investment accounted for under the fair value method), which has been presented separately and removed from net income (loss) from continuing operations as reported under GAAP. Net income (loss) from ongoing operations is a key financial and analytical measure used by management to gauge the operating performance of Tredegar’s ongoing operations. It is not intended to represent the stand-alone results for Tredegar’s ongoing operations under GAAP and should not be considered as an alternative to net income (loss) from continuing operations as defined by GAAP. It excludes items that we believe do not relate to Tredegar’s ongoing operations. |
Reconciliations of the pre-tax and post-tax balances attributed to net income (loss) from ongoing operations for the three and six months ended |
($ in millions) |
Pre-tax |
|
Tax Expense
|
|
After-Tax |
|
Effective
|
||||||||
Three Months Ended |
(a) |
|
(b) |
|
|
|
(b)/(a) |
||||||||
Net income (loss) from continuing operations reported under GAAP |
$ |
26.5 |
|
|
$ |
5.8 |
|
|
|
$ |
20.7 |
|
|
21.9 |
% |
(Gains) losses associated with plant shutdowns, asset impairments and restructurings |
0.2 |
|
|
0.1 |
|
|
|
0.1 |
|
|
|
||||
(Gains) losses from sale of assets and other |
(6.4 |
) |
|
(1.7 |
) |
|
|
(4.7 |
) |
|
|
||||
Net income (loss) from ongoing operations |
$ |
20.3 |
|
|
$ |
4.2 |
|
|
|
$ |
16.1 |
|
|
20.7 |
% |
Three Months Ended |
|
|
|
|
|
|
|
||||||||
Net income (loss) from continuing operations reported under GAAP |
$ |
18.2 |
|
|
$ |
3.9 |
|
|
|
$ |
14.3 |
|
|
21.2 |
% |
(Gains) losses from sale of assets and other |
1.8 |
|
|
0.1 |
|
|
|
1.7 |
|
|
|
||||
Net income (loss) from ongoing operations |
$ |
20.0 |
|
|
$ |
4.0 |
|
|
|
$ |
16.0 |
|
|
20.0 |
% |
Six Months Ended |
|
|
|
|
|
|
|
||||||||
Net income (loss) from continuing operations reported under GAAP |
$ |
39.2 |
|
|
$ |
8.9 |
|
|
|
$ |
30.3 |
|
|
22.5 |
% |
(Gains) losses associated with plant shutdowns, asset impairments and restructurings |
0.4 |
|
|
0.1 |
|
|
|
0.3 |
|
|
|
||||
(Gains) losses from sale of assets and other |
(5.9 |
) |
|
(1.5 |
) |
|
|
(4.4 |
) |
|
|
||||
Net income (loss) from ongoing operations |
$ |
33.7 |
|
|
$ |
7.5 |
|
|
|
$ |
26.2 |
|
|
22.3 |
% |
Six Months Ended |
|
|
|
|
|
|
|
||||||||
Net income (loss) from continuing operations reported under GAAP |
$ |
(8.7 |
) |
|
$ |
(2.4 |
) |
|
|
$ |
(6.3 |
) |
|
27.1 |
% |
(Gain) loss associated with the investment in kaléo |
24.8 |
|
|
5.3 |
|
|
|
19.5 |
|
|
|
||||
(Gains) losses from sale of assets and other |
5.8 |
|
|
1.6 |
|
|
|
4.2 |
|
|
|
||||
|
13.7 |
|
|
3.2 |
|
|
|
10.5 |
|
|
|
||||
Net income (loss) from ongoing operations |
$ |
35.6 |
|
|
$ |
7.7 |
|
|
|
$ |
27.9 |
|
|
21.4 |
% |
(g) |
Net debt is calculated as follows: |
|||||||||
|
|
|
|
|
||||||
(in millions) |
|
2021 |
|
2020 |
||||||
Debt |
|
$ |
117.0 |
|
|
$ |
134.0 |
|
||
Less: Cash and cash equivalents |
|
18.3 |
|
|
11.8 |
|
||||
Net debt |
|
$ |
98.7 |
|
|
$ |
122.2 |
|
Net debt is not intended to represent total debt as defined by GAAP. Net debt is utilized by management in evaluating the Company’s financial leverage and equity valuation, and management believes that investors also may find net debt to be helpful for the same purposes. |
(h) |
Represents a one-time tax credit in |
View source version on businesswire.com: https://www.businesswire.com/news/home/20210806005106/en/
neill.bellamy@tredegar.com
Source: